Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam toluenesulfonate for deep sedation during fiberoptic bronchoscopy
ChiCTR2100045543Phase 4Completed
- Sponsor
- Hainan Cancer Hospital
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of remimazolam in bronchopulmonary diseases, sponsored by Hainan Cancer Hospital. Primary endpoints: Incidence of serious adverse events, Incidence of solicited adverse events and 1 more. Started May 2021; status: completed.
02
Drugs
remimazolam
03
Conditions
bronchopulmonary diseases
Beyond the preview
Go deeper on ChiCTR2100045543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100045543.